Human movement company Scientific Analytics Inc reported on Wednesday the receipt of the US FDA's 510K medical device designation for its computer-vision-powered motion health analysis technology, DARI Health.
According to the company, its markerless DARI Motion computer vision and biomechanical analysis technology has been refined by more than 425bn data points of human motion gathered across applications in wellness, military, elite athletics and healthcare. It helps people and organisations to improve performance, avoid injury and reduce unnecessary costs.
Scientific Analytics has also formed a strategic collaboration with Hospital for Special Surgery (HSS), the world's largest academic musculoskeletal health company.
The newly formed partnership will integrate leading knowledge and technology with the aim of setting new standards for full-body, dynamic motion analysis at population scale. It will provide the first medical device that will arm clinicians with an FDA-cleared, accurate and reliable solution that easily and seamlessly captures clinically-relevant human movement data at the point of care.
Through the partnership, the companies aim to create a new standard in data-driven, value-based musculoskeletal health while objectively documenting outcomes and delivering an engaging patient experience.
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system
Bonesupport shifts CERAMENT V review to FDA's De Novo pathway
Neola Medical secures US patent for disposable lung monitoring probes
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Aetna to launch generative AI-powered conversational experience
Maxx Orthopedics Receives FDA 510(k) Clearance for Its Libertas® Bipolar Hip System
Ascletis Pharma announces ASC36 and ASC35 co-formulation for clinical development
Adocia files patent for long-acting peptide platform AdoXLong and updates on BioChaperone studies
Nurami Medical completes Phase 1 milestones in EIC-backed grant for Artifix